The purpose of this study is to investigate the relationship between ear fullness, pressure, and/or pain and laryngopharyngeal reflux, in order to focus medical therapy and improve therapeutic outcomes in this patient population.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
40mg, to be taken once daily by mouth, 30-60 minutes before meals, for at least 6 weeks
300mg, to be taken once daily by mouth, before bedtime, for at least 6 weeks
40mg, to be taken twice daily by mouth, 30-60 minutes before meals, for at least 6 weeks. (Alternative intervention if participant cannot tolerate omeprazole, is on an anticoagulant medication, or if on medication contraindicated for omeprazole and ranitidine)
11234 Anderson Street
Loma Linda, California, United States
1895 Orange Tree Lane, Suite 102
Redlands, California, United States
Evidence of laryngopharyngeal reflux in patients complaining of ear fullness/pressure/pain
Participants complaining of ear pain, ear fullness, or ear pain are diagnosed with laryngopharyngeal reflux via laryngoscope exam and measurement by diagnostic pH-probe test.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participants will undergo a routine clinical 24-hour diagnostic pH-probe test to assess quantitative measures for laryngopharyngeal reflux.
Participants will undergo routine clinical laryngoscopy to assess presence of laryngopharyngeal reflux.